Silexion Therapeutics Corp Overview
SLXN market data
Price HistoryDaily closing bars from the ranked market-data provider chain, not a live tape. The most recent bar is the last completed session, so it lags an open market.
SLXN price chart · 1M
- O
- 0.160100
- H
- 0.160100
- L
- 0.152600
- C
- 0.152700
- Vol
- 301.00
Daily history from Apr 9, 2021
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & PerformanceOpen, range, return and notional-volume facts calculated from daily market bars.
- Open
- $0.16
- Previous Close
- $0.17
- Day High
- $0.16
- Day Low
- $0.15
- 52 Week High
- $34.80
- 52 Week Low
- $0.15
- 7 Day Return
- -6.66%
- 30 Day Return
- -37.95%
- 90 Day Return
- -91.35%
- 1 Year Return
- -99.56%
- Daily Notional Volume
- $46 Latest daily bar volume multiplied by its closing price.
Valuation & ProfitabilityProvider-backed valuation, profitability, and range metrics for the selected company. Display-only; never feeds scores or decisions.
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$89.60 Diluted earnings per share over the trailing twelve months.
- Beta
- -0.31 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.14 – $35.60 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $2.4M · P/B 2.31.
Company NewsSymbol-tagged NewsEvent via getLatestNewsEventsBySymbol (Prisma first, Redis news:latest:v2 fallback). Operator cap 12 / public 10; low-signal filtered, headlines deduped. Display-only—scored signals stay on the separate signals surface.
10 captured
Silexion Therapeutics Announces First Patient Successfully Dosed in Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic CancerGlobenewswire Inc ·
Why FingerMotion Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving PremarketBenzinga ·
Silexion Therapeutics To Raise $837K Via Exercise Of ~3.217M Series E Warrants At $0.2603/ShareBenzinga ·